The companies in the healthcare industry are something special: Not only do they contribute to the economy; they also fight diseases. One of these companies is Celgene Corporation, a globally operating biopharmaceutical company that is represented by Celgene AB in Sweden. Celgene is primarily involved in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases.
In February 2013, Celgene Corporation was awarded the prestigious EURORDIS (The European Organisation for Rare Diseases) Company Award for excellence in the field of rare diseases.
Along with the achievements of other companies, the award recognizes Celgene’s medical commitment as well as its success story with several approved drugs for rare diseases and a number of other promising, innovative preparations.